ClinicalTrials HQ

Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys

Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys

Active, not recruiting · NCT05714514 · Registry updated 2025-11-18
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of KidneysKidney Transplantation in Highly Sensitized PatientsActive, not recruitingNot stated2025-11-18NCT05714514

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Hansa Biopharma AB4

14 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Cedars-Sinai Medical CenterLos AngelesUnited States392
Columbia UniversityNew YorkUnited States154
Cooperman Barnabas Medical CenterLivingstonUnited States64
Houston Methodist HospitalHoustonUnited States260
John Hopkins HospitalBaltimoreUnited States8
Massachusetts General HospitalBostonUnited States1015
Medical College of WisconsinMilwaukeeUnited States483
Methodist Hospital Specialty and TransplantSan AntonioUnited States1
New York University (NYU) Langone Transplant Institute, NYU Langone HealthNew YorkUnited States1
Northwestern University, Dept. General Surgery, Div. TransplantationChicagoUnited States1
University of Alabama at Birmingham (UAB) HospitalBirminghamUnited States1
University of Chicago, Department of Surgery, Clinical Research CenterChicagoUnited States1
University of Washington Medical CenterSeattleUnited States104
Washington University School of MedicineSt LouisUnited States895